Cargando…

The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease

Background and objective The prevalence of non-alcoholic fatty liver disease (NAFLD) is 60% in patients with type 2 diabetes mellitus (T2DM). NAFLD can lead to non-alcoholic steatohepatitis (NASH), both of which are the leading causes of cirrhosis. This study was undertaken to evaluate whether empag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pokharel, Arbinda, KC, Sudhamshu, Thapa, Pukar, Karki, Niyanta, Shrestha, Rupesh, Jaishi, Bikash, Paudel, Mukesh S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394637/ https://www.ncbi.nlm.nih.gov/pubmed/34466320 http://dx.doi.org/10.7759/cureus.16687

Ejemplares similares

Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease
por: Shrestha, Rupesh, et al.
Publicado: (2021)

Prevalence of Acute Kidney Injury in Patients with Liver Cirrhosis
por: Thapa, Pukar, et al.
Publicado: (2020)

Elevated Liver Enzymes in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease
por: Mandal, Amrendra, et al.
Publicado: (2018)

Masked Primary Hyperparathyroidism by Empagliflozin Use
por: Awada, Mariam, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus
por: Padda, Jaskamal, et al.
Publicado: (2021)

Adverse Side Effects: Empagliflozin-Related Acute Pancreatitis Case Report
por: Zeidan, Bassem S, et al.
Publicado: (2020)

A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis
por: Fernandez Felix, Daniel A, et al.
Publicado: (2022)

An Observational Study of Reduction in Glycemic Parameters and Liver Stiffness by Saroglitazar 4 mg in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
por: Mitra, Asis
Publicado: (2020)

Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit
por: Bteich, Fernand, et al.
Publicado: (2019)

Effectiveness of Empagliflozin With Vitamin D Supplementation in Peripheral Neuropathy in Type 2 Diabetic Patients
por: Mehta, Sanjana, et al.
Publicado: (2021)

Detection of Euglycemic Diabetic Ketoacidosis During Thoracic Surgery 75 Hours After Empagliflozin Discontinuation
por: Nishida, Ai, et al.
Publicado: (2022)

Prevalence of Portal Hypertensive Gastropathy in Chronic Liver Disease and Correlation with the Severity of Liver disease
por: Tiwari, Pratap S, et al.
Publicado: (2019)

Prevalence and Association of Elevated Liver Transaminases in Type 2 Diabetes Mellitus Patients in Jeddah, Saudi Arabia
por: Alzahrani, Sami H, et al.
Publicado: (2019)

Empagliflozin Ameliorates Progression From Prediabetes to Diabetes and Improves Hepatic Lipid Metabolism: A Systematic Review
por: Hossain, Md Fahad, et al.
Publicado: (2022)

Randomized Clinical Trial on Efficacy of Empagliflozin Versus Sitagliptin, In Addition to Metformin in Type 2 Diabetic Patients
por: Mubashir, Muaz, et al.
Publicado: (2022)

Revised Glycemic Index for Diagnosing and Monitoring of Diabetes Mellitus in South Indian Population
por: Khan, Rehana, et al.
Publicado: (2022)

Factors Predicting Mortality of Acute Variceal Bleeding in Liver Cirrhosis
por: Mandal, Amrendra Kumar, et al.
Publicado: (2018)

Effect of Dapagliflozin on Type 2 Diabetes Mellitus With Nonalcoholic Fatty Liver Disease: A Single-Center Survey
por: Das, Chandan, et al.
Publicado: (2021)

New-Onset Diabetes Mellitus (NODM) After Liver Transplantation (LT): The Ultimate Non-diabetogenic Immunosuppressive Therapy
por: Chaitou, Ali R, et al.
Publicado: (2022)

Association of Metabolic Dysfunction-Associated Steatotic Liver Disease/Non-alcoholic Fatty Liver Disease With Type 2 Diabetes Mellitus: A Case-Control Study in a Tertiary Care Hospital in Pakistan
por: Zahoor, Faizan, et al.
Publicado: (2023)

A Rare but Life-Threatening Case of Fournier’s Gangrene Caused by Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor, Empagliflozin
por: Jahir, Tahmina, et al.
Publicado: (2022)

A Comparison of the Effects of Empagliflozin and Sitagliptin, When Combined With Metformin, on Lipid Levels in Patients with Type 2 Diabetes: A Clinical Investigation
por: Ahmed, Mazhar, et al.
Publicado: (2023)

Prevalence of diabetes mellitus and associated risk factors in Nepal: findings from a nationwide population-based survey
por: Shrestha, Namuna, et al.
Publicado: (2022)

Direct-Acting Antivirals in the Treatment of Hepatitis C Virus (HCV)/Human Immunodeficiency Virus (HIV) Co-infected Patients: Real-Life Experience From Nepal
por: KC, Sudhamshu, et al.
Publicado: (2021)

Management of Diabetic Ketoacidosis in a Patient With Chronic Kidney Disease Under Maintenance Hemodialysis: A Case Report
por: Regmi, Milan, et al.
Publicado: (2023)

Ketogenic Diet-induced Elevated Cholesterol, Elevated Liver Enzymes and Potential Non-alcoholic Fatty Liver Disease
por: Anekwe, Chika V, et al.
Publicado: (2020)

Comparative Study of the Effects of Azilsartan and Telmisartan on Insulin Resistance and Metabolic Biomarkers in Essential Hypertension Associated With Type 2 Diabetes Mellitus
por: Meher, Bikash R, et al.
Publicado: (2022)

Rhabdomyolysis Secondary to Severe Hypothyroidism Due to Hashimoto’s Thyroiditis: A Case Report
por: Munankami, Salina, et al.
Publicado: (2023)

Study of Gonadal Hormones in Males With Liver Cirrhosis and Its Correlation With Child-Turcotte-Pugh and Model for End-Stage Liver Disease Scores
por: Vaishnav, Bhumika, et al.
Publicado: (2023)

Metabolic Syndrome in Patients with Non-alcoholic Fatty Liver Disease: A Community Based Cross-sectional study
por: Paudel, Mukesh S, et al.
Publicado: (2019)

Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
por: Kumari, Bandana, et al.
Publicado: (2021)

Prognostic Significance of Diastolic Dysfunction in Type 2 Diabetes Mellitus Patients With Sepsis and Septic Shock: Insights From a Longitudinal Tertiary Care Study
por: Thockchom, Nonita, et al.
Publicado: (2023)

Concealed Malignancy as a Rare Cause of Refractory Lactic Acidosis: A Fatal Case
por: Khan Suheb, Mahammed Z, et al.
Publicado: (2021)

Chronic Liver Disease and the Risk of Osteoporotic Fractures: A Meta-Analysis
por: Hidalgo, Diego F, et al.
Publicado: (2020)

Thyroid Storm-Induced Acute Liver Dysfunction and Disseminated Intravascular Coagulation
por: Kim, Yungmin, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Hypothyroidism: What You Need to Know
por: Bikeyeva, Viktoriya, et al.
Publicado: (2022)

New Evidence in the Pathogenesis of Celiac Disease and Type 1 Diabetes Mellitus: A Systematic Review
por: Prieto, Jose, et al.
Publicado: (2021)

Acute Liver Injury Induced by Sitagliptin: Report of Two Cases and Review of Literature
por: Shahbaz, Amir, et al.
Publicado: (2018)

Thyroid Storm Presenting as Acute Liver Failure in a Patient with Graves’ Disease
por: Hayat, Muhammad Hashim, et al.
Publicado: (2020)

The Role of Thiazolidinediones in the Amelioration of Nonalcoholic Fatty Liver Disease: A Systematic Review
por: Ndakotsu, Andrew, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j3poudfvgh7dcbffasr5i2b36u